Skip to content

Clinical trials

Terminated Phase 2 Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Status: Terminated Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20054
20063
20072
20083
20093
20113
20123
20132
20141
20154
20161
20174
20184
20191
20203
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
AstraZeneca3
GlaxoSmithKline3
Novartis Pharmaceuticals3
Pfizer3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Columbia University2
FLUIDDA nv2
Actelion1
Aeris Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive49
Asthma3
Bronchiectasis2
Emphysema2
Hypertension, Pulmonary2
Inflammation2
Acute Lung Injury1
Bronchiolitis Obliterans1
Bronchitis, Chronic1
Carcinoma in Situ1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.